New heart implant could replace blood thinners for AFib patients
NCT ID NCT05224375
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tested a device called the Laminar Left Atrial Appendage Closure System in 29 people with atrial fibrillation who cannot take blood thinners. The device is implanted to seal off a small pouch in the heart where clots often form. The goal was to see if it is safe and effective at reducing stroke risk without the need for long-term medication.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Laminar Left Atrial Appendage Closure System (a device implanted to seal off part of the heart)
What this could lead to
If successful, this device could offer a long-term alternative to blood thinners for preventing strokes in people with atrial fibrillation.
What could go wrong
This was a small early study with only 29 participants, so results may not apply to everyone. There are risks like stroke, bleeding, or need for additional procedures.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tbilisi Heart and Vascular Clinic
Tbilisi, Georgia